Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Emflaza (deflazacort) for the Treatment of Duchenne Muscular Dystrophy

Drug (Brand / Generic)

Emflaza / deflazacort

Developer

Marathon Pharmaceuticals

Therapy Class

Anti-inflammatory or immunosuppressant

Product Description

Glucocorticoid

Current Indication

Duchenne muscular dystrophy (DMD)

Market Sector

Musculoskeletal disorders

Development Status

Approved in the US
Expand

Go Top